Fludarabine, cyclophosphamide, and rituximab as first‐line treatment in patients with chronic lymphocytic leukemia: A long‐term analysis of the German CLL Study Group (GCLLSG) registry. - Kutsch, Nadine; Giza, Adam; Robrecht, Sandra; Stumpf, Janina; Federhen, Anno; Stoltefuß, Andrea; Vehling‐Kaiser, Ursula; Koenigsmann, Michael; Tausch, Eugen; Schneider, Christof; Stilgenbauer, Stephan; Illmer, Thomas; et al. (European Journal of Haematology, 2024)